Hamza Kandoussi
Impact in
- Hepatology top 2%
- Hepatitis C virus research
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in
- Hepatology 12
- Hepatitis C virus research 12
-
- Pharmacogenetics and Drug Metabolism 5
- Drug-Induced Hepatotoxicity and Protection 2
- Co-authors
- Marc Bifano (12 shared papers)Richard Bertz (11 shared papers)Carey Hwang (7 shared papers)Jianing Zeng (10 shared papers)Hao Jiang (7 shared papers)Τushar Garimella (8 shared papers)Mark E. Arnold (7 shared papers)Hong Shen (5 shared papers)
- Journals
- Antiviral Therapy (4 papers)Bioanalysis (4 papers)Drug Metabolism and Disposition (3 papers)Journal of Pharmaceutical and Biomedical Analysis (3 papers)Analytical Chemistry (2 papers)
- Partner nations
- United StatesGermanySweden
In The Last Decade
Hamza Kandoussi
24 papers receiving 561 citations
Peers
Comparison fields: 5 of 62
- Hepatology 298
- Pharmacology 102
- Infectious Diseases 150
- Oncology 138
- Epidemiology 148
Countries citing papers authored by Hamza Kandoussi
This map shows the geographic impact of Hamza Kandoussi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamza Kandoussi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamza Kandoussi more than expected).
Fields of papers citing papers by Hamza Kandoussi
This network shows the impact of papers produced by Hamza Kandoussi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamza Kandoussi. The network helps show where Hamza Kandoussi may publish in the future.
Co-authors
The 25 scholars most cited alongside Hamza Kandoussi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 72 | |
| 2 | 2015 | 60 | |
| 3 | 2018 | 50 | |
| 4 | 2014 | 40 | |
| 5 | 2012 | 38 | |
| 6 | 2012 | 33 | |
| 7 | 2015 | 29 | |
| 8 | 2015 | 29 | |
| 9 | 2014 | 27 | |
| 10 | 2020 | 26 | |
| 11 | 2011 | 24 | |
| 12 | 2016 | 23 | |
| 13 | 2015 | 22 | |
| 14 | 2014 | 17 | |
| 15 | 2018 | 17 | |
| 16 | 2013 | 14 | |
| 17 | 2016 | 11 | |
| 18 | 2013 | 8 | |
| 19 | 2015 | 7 | |
| 20 | 2014 | 6 |
About Hamza Kandoussi
Hamza Kandoussi is a scholar working on Hepatology, Pharmacology, Infectious Diseases, Oncology and Pediatrics, Perinatology and Child Health, having authored 25 papers that have together received 573 indexed citations. Recurring topics across this work include Hepatitis C virus research (12 papers), Drug Transport and Resistance Mechanisms (6 papers), HIV/AIDS drug development and treatment (6 papers), Pharmacogenetics and Drug Metabolism (5 papers), Pharmacological Effects and Toxicity Studies (3 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Metabolism and Genetic Disorders (1 paper). The work is most often cited by research in Hepatology (298 citations), Pharmacology (102 citations), Infectious Diseases (150 citations), Oncology (138 citations) and Epidemiology (148 citations). Hamza Kandoussi has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include Marc Bifano, Richard Bertz, Carey Hwang, Jianing Zeng, Hao Jiang, Τushar Garimella, Mark E. Arnold, Hong Shen, Timothy Eley and Dennis M. Grasela. Their work appears in journals such as Antiviral Therapy, Bioanalysis, Drug Metabolism and Disposition, Journal of Pharmaceutical and Biomedical Analysis and Analytical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.